Lokahi Longevity has launched a program advocating universal hs-CRP testing to assess cardiovascular inflammation risk, as called for by the American College of Cardiology’s recent Scientific Statement. This simple blood test helps assess the risk of major adverse cardiovascular events (MACE), such as heart attack and stroke independent of LDL cholesterol.